ResearchMy interest is in understanding how stem cell biology can be used to develop more effective therapies for blood diseases and cancer.
Dr. David Scadden shares his thoughts on the new executive order.
MGH Hotline 05.14.10 Researchers from the Center for Regenerative Medicine gathered with Cheryl Chagnon, Heather Reid and their families April 6 to celebrate the donation of an important piece of research equipment -- the Nexelcom Cellometer Vision automatic cell analyzer.
MGH Hotline 08.06.10 In General awards and honors
MGH Hotline 12.24.10 In General awards and honors
MGH Hotline 5.27.11
In General awards and honors
A new study by Harvard researchers at Massachusetts General Hospital indicates that “good” cells can become cancerous because of exposure to a “bad” environment within the body — similarly to the way a “good boy” may turn to crime when exposed to the pressures of life in a crime-ridden neighborhood.
MGH investigators have identified a new mechanism that controls the number of the stem cells that give rise to all blood and immune system cells, an advance that may improve treatment of blood system cancers.
A study comparing how blood stem cells and leukemia cells consume nutrients found that cancer cells are far less tolerant to shifts in their energy supply than their normal counterparts. The results suggest that there could be ways to target leukemia metabolism so that cancer cells die but other cell types are undisturbed.